FINILBRI Trademark
Trademark Overview
On Monday, October 11, 2021, a trademark application was filed for FINILBRI with the United States Patent and Trademark Office. The USPTO has given the FINILBRI trademark a serial number of 97068224. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2024. This trademark is owned by Alexion Pharmaceuticals, Inc.. The FINILBRI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, protein aggregation-related diseases and disorders, neurodegenerative diseases and disorders
General Information
| Serial Number | 97068224 |
| Word Mark | FINILBRI |
| Filing Date | Monday, October 11, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, January 8, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 12, 2022 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, protein aggregation-related diseases and disorders, neurodegenerative diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 2, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Alexion Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
| Party Name | Alexion Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02210 |
Trademark Events
| Event Date | Event Description |
| Thursday, October 14, 2021 | NEW APPLICATION ENTERED |
| Tuesday, November 2, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 25, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, March 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 12, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 12, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 7, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 22, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 22, 2022 | SOU EXTENSION 1 FILED |
| Tuesday, November 22, 2022 | SOU EXTENSION 1 GRANTED |
| Thursday, November 24, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, May 6, 2023 | SOU TEAS EXTENSION RECEIVED |
| Saturday, May 6, 2023 | SOU EXTENSION 2 FILED |
| Saturday, May 6, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, May 9, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, January 8, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, January 8, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 7, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
